Testosterone for Women in Menopause: When Might It Help?

A change in desire during menopause can be hard to talk about. Testosterone is one possible discussion when low desire persists, causes distress and is not better explained by another concern. It is not a general treatment for fatigue, brain fog, bone loss or every change in sex drive. A clinician should ask what has changed, how it affects you, and what else might be involved before considering treatment. The International Society for the Study of Women’s Sexual Health (ISSWSH) guideline describes a narrow role for systemic testosterone in selected women with hypoactive sexual desire disorder (HSDD), along with important limits.

Why does testosterone come up during menopause?

Women produce testosterone, and levels can change with age or after removal of the ovaries. But a symptom does not prove a testosterone deficiency, and a hormone prescription may not solve it. Desire is affected by physical comfort, sleep, mood, medicines, relationships and many other factors. The Menopause Society’s sexual-health guide explains why a conversation about desire needs more than a hormone number.

Some women notice a change that does not trouble them; others find it deeply disruptive. What the change means to you matters. A clinician can help separate a persistent desire concern from pain with sex, vaginal dryness, fatigue or another condition that needs a different approach.

When might treatment be considered for low desire?

The strongest evidence is for selected postmenopausal women with HSDD, after a broader assessment. HSDD is not diagnosed by a low testosterone result. It involves a persistent loss of desire that causes distress and is not better accounted for by another issue. The ISSWSH guideline calls for a biopsychosocial assessment before a treatment decision. This means discussing health, sexual experience, mood, relationship context and medicines as well as any relevant examination or tests.

Before any prescription, ask what benefit is realistic, what remains uncertain and what other choices you have. A blood testosterone measurement may provide a baseline for monitoring, but the guideline says it should not be used to diagnose HSDD. A clinician may decide that another concern should be addressed first. No single test or symptom list can make that choice for you.

What benefit is supported, and what remains uncertain?

Trials considered in the ISSWSH guideline found a moderate benefit for sexual desire and related sexual function in selected women with HSDD. That finding does not mean testosterone reliably restores energy, mood, memory, muscle or bone strength. The FDA’s 2026 public meeting identified continuing questions about benefits beyond sexual function and long-term safety.

Short-term studies have not resolved long-term safety. Acne, increased body hair and other signs of androgen exposure are possible. A clinician must also consider your medical history and treatment goals. The absence of a concerning effect in a short study is not a guarantee for an individual over years of use.

What matters about the product and follow-up?

There is no FDA-approved testosterone product specifically for women in the United States for this purpose. The FDA’s testosterone information describes current products as approved for use in men with associated medical conditions. Treatment for a woman therefore raises an off-label discussion. The ISSWSH guideline describes careful use of an approved transdermal product in an appropriate amount when a clinician and patient decide to proceed. It advises against compounded testosterone, pellets, injections and oral preparations for HSDD because of efficacy, safety or dose-control concerns.

Before treatment, ask what product would be used, why it is being considered, how response and adverse effects would be monitored, and when the plan would be reconsidered. Do not use a suggested dose from an article. These details belong in an informed conversation with the prescribing clinician.

What else could be affecting sexual desire?

Pain or dryness can make intimacy unwelcome even when desire itself is not the only issue. Sleep problems, mood changes, medication effects and relationship circumstances may also contribute. Describe what you are experiencing in your own words; you do not need to name the cause first. DPC’s separate vaginal dryness guide addresses one common physical concern in more detail.

If you want to discuss a change in sexual desire, bring the questions that matter to you: how long it has been present, whether it causes distress, whether sex is painful, what medications you take and what you hope would improve. The women’s hormone-health program is a place to ask about an individual assessment, not a promise that testosterone will be prescribed or will produce a particular result.